Like cytokine-polarized TAMs and MDSCs, we found that tumor-cell-differentiated MARCO+ TCM, independent of cell-to-cell contact, could suppress cytotoxic T cell and NK cell IFNγ production, proliferation, and/or degranulation (CD107a). The gene discussed is IFNG; the disease is neoplasm.